Recently, Li et al. reported that inhibition of STAT3 activity in breast cancer metastasis model simultaneously impaired matrix metalloproteinase (MMP)-2/9 and ROS generation and increased the CD8+ T cells in the TME [158]. This evidence concerns the gene STAT3 and breast carcinoma.